Effect of UGT1A4, UGT2B7, UGT2B15, UGT2B17 and ABC1B polymorphisms on lamotrigine metabolism in Danish patients

被引:13
作者
Petrenaite, Vaiva [1 ,2 ,6 ]
Ohman, Inger [3 ]
Jantzen, Frederik Peter Thal [4 ,5 ]
Ekstrom, Lena [5 ]
机构
[1] Univ Hosp Copenhagen, Herlev & Gentofte Hosp, Dept Neurol, Copenhagen, Denmark
[2] Univ Hosp Copenhagen, Dept Neurol, Epilepsy Clin, Rigshospitalet Glostrup & Blegdamsvej, Copenhagen, Denmark
[3] Karolinska Inst, Ctr Pharmacoepidemiol, Dept Med, Stockholm, Sweden
[4] Univ Hosp Copenhagen, Bispebjerg & Frederiksberg Hosp, Dept Neurol, Copenhagen, Denmark
[5] Karolinska Univ Hosp, Div Clin Pharmacol, Dept Lab Med, Karolinska Inst, Stockholm, Sweden
[6] Univ Hosp Copenhagen, Dept Neurol, Epilepsy Clin, Herlev & Gentofte, Borgmester Ib Juuls Vej 1, DK-2730 Herlev, Denmark
关键词
Lamotrigine; UGT; Polymorphism; Transporter; Glucuronide; Epilepsy; UDP-GLUCURONOSYLTRANSFERASE; SERUM CONCENTRATION; VALPROIC ACID; PLASMA-CONCENTRATIONS; CHINESE CHILDREN; PHARMACOKINETICS; GLUCURONIDATION; ASSOCIATION;
D O I
10.1016/j.eplepsyres.2022.106897
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To evaluate the impact of genetic polymorphisms of UGT enzymes (UGT1A4, UGT2B7, UGT2B15 and UGT 2B17) and the transporter protein ABCB1 on Lamotrigine (LTG) metabolism.Methods: Single nucleotide polymorphisms UGT1A4*2 (P24T, c.70C > A), UGT1A4*3 (L48V c.142T > G), UGT2B7*2 (H802Y, c.802C > T), UGT2B15*2 (Y85D, c.253G > T), UGT2B17 deletion and transporters ABC 1236C > T and 3435C > T were determined in 337 Caucasian patients with epilepsy treated with LTG in Denmark. The prospectively collected data included LTG dosage, LTG plasma concentration, 2-N-GLU concen-tration, sex, smoking habits, concomitant medicine, oral contraceptives (OC).Results: The non-smokers with LTG monotherapy and LTG polytherapy with other non-interacting drugs NIAEDs (n = 199) were analyzed separately in univariant analyses. LTG ratios (LTG plasma concentration/ (LTG dose/ weight)) in patients carrying wild type UGT1A4*2 C-allele were 22% lower than in heterozygous C-carriers (p = 0.013). Patients with UGT2B7*2 polymorphism TT genotype had 1.2-fold higher LTG ratios (p = 0.0078) and 0.78-fold lower GLU/LTG ratio (p = 0.0275) than patients homozygous for the C allele. The similar significant findings were also seen comparing homozygotes (TT) with heterozygotes patients (CT). Individuals homozygous for the UGT2B15*2 T allele displayed 18% lower LTG ratio concentrations than individuals homozygous for the G allele (p = 0.014),while significant difference in GLU/LTG ratio was only seen comparing wild type with homozygous patients (GG versus TT, p = 0.031). A copy number variation gene deletion polymorphism of UGT2B17 showed that individuals devoid of the gene (del/del) exhibited 1.3-fold higher LTG ratio (p = 0.015). For ABCB1c.1236 C > T and ABC1B1c.3435 C > T no associations with LTG and GLU ratios were found. Sex specific differences in enzyme activity (most prominent effect in women) on LTG metabolism were found for UGT2B15, UGT2B17, UGT1A4 and UGT2B7 polymorphisms. Multiple regression analysis confirmed the significant effect of OC, VPA and UGT1A4 * 2 and UGT2B7 * 2 on LTG metabolism.Conclusion: Our study confirms the previous findings that genetic variations in UGT2B7 and UGT1A4 genes are associated with serum LTG concentrations. Furthermore, our results indicate that it is possible that different UGT genotypes may exert larger impact on LTG metabolism in women than in men.
引用
收藏
页数:7
相关论文
共 33 条
[1]   Variation in glucuronidation of lamotrigine in human liver microsomes [J].
Argikar, U. A. ;
Remmel, R. P. .
XENOBIOTICA, 2009, 39 (05) :355-363
[2]   Determination of lamotrigine and its metabolites in human plasma by liquid chromatography-mass spectrometry [J].
Beck, Olof ;
Ohman, Inger ;
Nordgren, Helena K. .
THERAPEUTIC DRUG MONITORING, 2006, 28 (05) :603-607
[3]   Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: ethnic diversity of alleles and potential clinical significance [J].
Bhasker, CR ;
McKinnon, W ;
Stone, A ;
Lo, ACT ;
Kubota, T ;
Ishizaki, T ;
Miners, JO .
PHARMACOGENETICS, 2000, 10 (08) :679-685
[4]   Correlation of the UGT1A4 gene polymorphism with serum concentration and therapeutic efficacy of lamotrigine in Han Chinese of Northern China [J].
Chang, Ying ;
Yang, Li-ya ;
Zhang, Meng-chao ;
Liu, Song-Yan .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 70 (08) :941-946
[5]   CHARACTERIZATION OF A CLONED HUMAN DIHYDROTESTOSTERONE ANDROSTANEDIOL UDP-GLUCURONOSYLTRANSFERASE AND ITS COMPARISON TO OTHER STEROID ISOFORMS [J].
CHEN, F ;
RITTER, JK ;
WANG, MG ;
MCBRIDE, OW ;
LUBET, RA ;
OWENS, IS .
BIOCHEMISTRY, 1993, 32 (40) :10648-10657
[6]   Oral contraceptives induce lamotrigine metabolism:: Evidence from a double-blind, placebo-controlled trial [J].
Christensen, Jakob ;
Petrenaite, Vaiva ;
Atterman, Jorn ;
Sidenius, Per ;
Ohman, Inger ;
Tomson, Torbjorn ;
Sabers, Anne .
EPILEPSIA, 2007, 48 (03) :484-489
[7]   UDP-glucuronosyltransferase (UGT) 2B15 pharmacogenetics: UGT2B15 D85Y genotype and gender are major determinants of oxazepam glucuronidation by human liver [J].
Court, MH ;
Hao, Q ;
Krishnaswamy, S ;
Bekaii-Saab, T ;
Al-Rohaimi, A ;
von Moltke, LL ;
Greenblatt, DJ .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 310 (02) :656-665
[8]   Association of UGT2B7 and UGT1A4 Polymorphisms with Serum Concentration of Antiepileptic Drugs in Children [J].
Du, Zhongliang ;
Jiao, Yukun ;
Shi, Lianting .
MEDICAL SCIENCE MONITOR, 2016, 22 :4107-4113
[9]   The UDP-glucuronosyltransferase 2B17 gene deletion polymorphism: Sex-specific association with urinary 4-(methyinitrosamino)-1-(3-pyridyl)-1-butanol glucuroniclation phenotype and risk for lung cancer [J].
Gallagher, Carla J. ;
Muscat, Joshua E. ;
Hicks, Amy N. ;
Zheng, Yan ;
Dyer, Anne-Marie ;
Chase, Gary A. ;
Richie, John ;
Lazarus, Philip .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (04) :823-828
[10]   Carriers of the UGT1A4 142T>G gene variant are predisposed to reduced olanzapine exposure-an impact similar to male gender or smoking in schizophrenic patients [J].
Ghotbi, Roza ;
Mannheimer, Buster ;
Aklillu, Eleni ;
Suda, Akira ;
Bertilsson, Leif ;
Eliasson, Erik ;
Osby, Urban .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 66 (05) :465-474